Figure 5 — Allicin treats myocardial infarction in I/R through the promotion of the SHP2 axis to inhibit p-PERK-mediated oxidative stress

Research Paper|Volume 16, Issue 6|pp. 5207–5223

Allicin treats myocardial infarction in I/R through the promotion of the SHP2 axis to inhibit p-PERK-mediated oxidative stress

Back to articleFigure 5(5 of 8)

100%

Figure 5.Detection of SHP2 expression using RT-PCR and immunofluorescence. (A) RT-PCR analysis of SHP2 mRNA expression, with corresponding statistical data. One-way analysis, **p < 0.01, n = 6/group. (B) Immunofluorescence staining for SHP2 expression and statistical analysis. One-way analysis, **p < 0.01, n = 6/group. (C) SHP2 fluorescence intensity statistical analysis. One-way analysis, **p < 0.01, n = 6/group.